Abstract
Rhythm control therapy by sodium channel blockers is widely performed for the treatment of paroxysmal atrial fibrillation. Here, we present a case of acquired Brugada syndrome by pill-in-the-pocket treatment using pilsicainide. It is important that this therapy should be applied only after confirming the drug safety to the patients.
Original language | English |
---|---|
Pages (from-to) | 139-140 |
Number of pages | 2 |
Journal | Drug, Healthcare and Patient Safety |
Volume | 2 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2010 |
Keywords
- Atrial flutter
- Drug
- Pilsicainide
- Rhythm control
- Sudden death
- Syncope
ASJC Scopus subject areas
- Pharmacology
- Health Policy